According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

Pulmonary arterial hypertension (PAH) is a rare, progressive disorder impacting small pulmonary arteries, leading to increased vascular resistance and heart failure. The latest report forecasts ...

Those battling severe asthma, upper respiratory tract diseases, Chronic Obstructive Pulmonary Disease (COPD), Asbestosis and ...

Frequent consumption of a common drug that acts on the nervous system and treats a range of ailments may lead to faster ...

Thousands of people struggling with common respiratory conditions could be able to get extra financial support from the ...

“This is my home, and now I’ve got to leave it and start over,” Hedley said this week as she packed up her final boxes prior ...

Freshfields is advising Merck on its $10bn acquisition of respiratory-focused pharmaceutical company Verona Pharma, in a ...

WITH THE INCREASING focus on sustainability, organisations across all sectors are expected to go beyond box-ticking and prove their environmental and social responsibility. Two frameworks guiding ...